
News
New Approach to Cancer Immunotherapy Improves Efficacy and Decreases Toxicity
Researchers from the University of Notre Dame and Stanford University have developed a new approach for cancer immunotherapy that promises to improve efficacy and reduce systemic immune activation toxicity.




























